CD38 and Miyoshi myopathy: Because CD38 is not exclusively expressed MM cells, off-target effects include NK depletion via cell fratricide as well as immunoparesis (defined as the reduction in levels of ≥1 immunoglobulins not associated with the patient’s specific myeloma variant) resulting from depletion of the antibody-producing plasma/B-cell population [178,179].